A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy

Active:	Yes
Cancer Type:	Bone Tumor	NCT ID:	NCT06859801
Trial Phases:		Protocol IDs:	SIO-2025-01 (primary) NCI-2025-05519
Eligibility:	21 Years and older, Male and Female	Study Type:	Other
Study Sponsor:	Society of Interventional Oncology
NCI Full Details:	http://clinicaltrials.gov/show/NCT06859801

Summary

The objective of this study is to evaluate real-world outcomes (e.g., pain, patient
reported outcomes, skeletal related events, healthcare utilization, etc.) in patients
treated with both percutaneous ablation and palliative radiation therapy (RT).

Treatment Sites in Georgia

Northside Hospital Cancer Institute
1000 Johnson Ferry Road NE
Atlanta, GA 30342
404-303-3355
www.northside.com

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.